The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase .beta. (LPAAT-.beta.) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-.beta. activity.

 
Web www.patentalert.com

< Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof

< Tetraphenylbacteriochlorin derivatives and compositions containing the same

> Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

> Camptothecin intermediates and prodrugs and methods of preparation thereof
~ 00272